For pharmaceutical companies, regulatory leadership is not optional, it is foundational. Every submission, approval, and compliance decision directly impacts product timelines, patient safety, and business continuity. When a U.S.-based pharmaceutical organization faced a sudden leadership gap in its Vice President of Regulatory Affairs role, the stakes were exceptionally high.